Our mission is to apply our in-depth experience and expertise in clinical research and drug development to lead our clients’ compounds and devices toward regulatory approval.
InClinica is a global clinical CRO that specializes in leading companies through clinical trials. The company was founded in 2016 through the acquisition of an existing global clinical CRO.
Our senior management team has more than a century of internal drug development experience.
We have experience in multiple diseases and device technologies, conducted across all stages of clinical trials, in North America, Asia/Pacific, Europe and Latin America.